Abadan, Rogen P.
HRN: 21-32-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2022
CEFUROXIME 500MG (TAB)
05/10/2022
05/16/2022
ORAL
500mg/tab
BID
S/P Primary LTCS; EL; Appendectomy; Lavage
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes